NCT03232580View on ClinicalTrials.gov

99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

November 12, 2018

Study Completion Date

November 12, 2018

Conditions
Spondyloarthritis
Interventions
DRUG

rhAnnexin V-128

All patients received a single i.v injection of 99mTc-rhAnnexin V-128 at Day 0.

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Advanced Accelerator Applications

INDUSTRY